• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

The elusive goal of COVID-19 vaccine immunity.

作者信息

Abu-Raddad Laith J, Chemaitelly Hiam

机构信息

Infectious Disease Epidemiology Group, Weill Cornell Medicine-Qatar, Cornell University, Doha 24144, Qatar; World Health Organization Collaborating Centre for Disease Epidemiology Analytics on HIV/AIDS, Sexually Transmitted Infections, and Viral Hepatitis, Weill Cornell Medicine-Qatar, Cornell University, Doha 24144, Qatar; Department of Population Health Sciences, Weill Cornell Medicine, Cornell University, New York, NY, USA; Department of Public Health, College of Health Sciences, QU Health, Qatar University, Doha, Qatar.

Infectious Disease Epidemiology Group, Weill Cornell Medicine-Qatar, Cornell University, Doha 24144, Qatar; World Health Organization Collaborating Centre for Disease Epidemiology Analytics on HIV/AIDS, Sexually Transmitted Infections, and Viral Hepatitis, Weill Cornell Medicine-Qatar, Cornell University, Doha 24144, Qatar; Department of Population Health Sciences, Weill Cornell Medicine, Cornell University, New York, NY, USA.

出版信息

Lancet Respir Med. 2023 Feb;11(2):115-117. doi: 10.1016/S2213-2600(22)00394-0. Epub 2022 Oct 7.

DOI:10.1016/S2213-2600(22)00394-0
PMID:36216010
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC9544938/
Abstract
摘要
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/effa/9544938/706828914156/fx1_lrg.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/effa/9544938/706828914156/fx1_lrg.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/effa/9544938/706828914156/fx1_lrg.jpg

相似文献

1
The elusive goal of COVID-19 vaccine immunity.新冠疫苗免疫这一难以实现的目标。
Lancet Respir Med. 2023 Feb;11(2):115-117. doi: 10.1016/S2213-2600(22)00394-0. Epub 2022 Oct 7.
2
Trusting COVID-19 vaccines as individual and social goal.信任 COVID-19 疫苗是个人和社会的目标。
Sci Rep. 2022 Jun 8;12(1):9470. doi: 10.1038/s41598-022-13675-3.
3
COVID-19 vaccines and vaccination: how prepared is Africa?COVID-19 疫苗和接种：非洲准备得如何？
Pan Afr Med J. 2021 Jun 4;39:107. doi: 10.11604/pamj.2021.39.107.27912. eCollection 2021.
4
Postinfectious Immunity After COVID-19 and Vaccination Against SARS-CoV-2.新冠病毒感染后与 SARS-CoV-2 疫苗接种的感染后免疫
Viral Immunol. 2021 Oct;34(8):504-509. doi: 10.1089/vim.2021.0054. Epub 2021 Jul 5.
5
Antibody and T cell immune responses following mRNA COVID-19 vaccination in patients with cancer.癌症患者接种新冠病毒mRNA疫苗后的抗体和T细胞免疫反应。
Cancer Cell. 2021 Aug 9;39(8):1034-1036. doi: 10.1016/j.ccell.2021.07.016. Epub 2021 Jul 27.
6
COVID-19 optimal vaccination policies: A modeling study on efficacy, natural and vaccine-induced immunity responses.新冠病毒病（COVID-19）的最佳疫苗接种策略：一项关于效力、自然免疫和疫苗诱导免疫反应的建模研究
Math Biosci. 2021 Jul;337:108614. doi: 10.1016/j.mbs.2021.108614. Epub 2021 May 4.
7
The COVID-19 Vaccine: Trust, doubt, and hope for a future beyond the pandemic in Germany.《COVID-19 疫苗：德国大流行后对未来的信任、怀疑和希望》
PLoS One. 2022 Apr 7;17(4):e0266659. doi: 10.1371/journal.pone.0266659. eCollection 2022.
8
COVID-19 Vaccine-Related Discussion on Twitter: Topic Modeling and Sentiment Analysis.新冠疫苗相关推文的讨论：主题建模和情感分析。
J Med Internet Res. 2021 Jun 29;23(6):e24435. doi: 10.2196/24435.
9
Unravelling the enhanced vaccine immunity by heterologous KCONVAC/Ad5-nCoV COVID-19 vaccination.解析异源KCONVAC/Ad5-nCoV新冠疫苗接种增强疫苗免疫的机制
Signal Transduct Target Ther. 2022 Jul 4;7(1):210. doi: 10.1038/s41392-022-01079-8.
10
COVID-19 vaccines mix-and-match: The concept, the efficacy and the doubts.COVID-19 疫苗混打：概念、效果和疑虑。
J Med Virol. 2022 Apr;94(4):1294-1299. doi: 10.1002/jmv.27463. Epub 2021 Nov 30.

引用本文的文献

1
Dynamic Trends and Underlying Factors of COVID-19 Vaccine Booster Hesitancy in Adults: Cross-Sectional Observational Study.成年人对 COVID-19 疫苗加强针犹豫不决的动态趋势和潜在因素：横断面观察性研究。
JMIR Public Health Surveill. 2023 Aug 1;9:e44822. doi: 10.2196/44822.
2
Role of previous infection with SARS-CoV-2 in protecting against omicron reinfections and severe complications of COVID-19 compared to pre-omicron variants: a systematic review.奥密克戎变异株与新冠前变异株相比，既往感染 SARS-CoV-2 在预防再感染和 COVID-19 严重并发症方面的作用：系统评价。
BMC Infect Dis. 2023 Jun 26;23(1):432. doi: 10.1186/s12879-023-08328-3.
3

本文引用的文献

1
Effectiveness and durability of BNT162b2 vaccine against hospital and emergency department admissions due to SARS-CoV-2 omicron sub-lineages BA.1 and BA.2 in a large health system in the USA: a test-negative, case-control study.辉瑞-BioNTech 疫苗对美国大型医疗体系内因 SARS-CoV-2 奥密克戎 BA.1 和 BA.2 亚系导致的住院和急诊科就诊的有效性和持久性：一项病例对照研究
Lancet Respir Med. 2023 Feb;11(2):176-187. doi: 10.1016/S2213-2600(22)00354-X. Epub 2022 Oct 7.
2
Effectiveness of COVID-19 vaccines against Omicron and Delta hospitalisation, a test negative case-control study.新冠病毒疫苗对奥密克戎和德尔塔毒株导致住院治疗的有效性：一项检测呈阴性的病例对照研究
Nat Commun. 2022 Sep 30;13(1):5736. doi: 10.1038/s41467-022-33378-7.
3
Future COVID-19 Booster Vaccine Refusal in Healthcare Workers after a Massive Breakthrough Infection Wave, a Nationwide Survey-Based Study.
大规模突破性感染浪潮后医护人员未来拒绝接种新冠病毒加强疫苗的情况：一项基于全国调查的研究
Vaccines (Basel). 2023 May 16;11(5):987. doi: 10.3390/vaccines11050987.
Duration of immune protection of SARS-CoV-2 natural infection against reinfection.
SARS-CoV-2 自然感染对再次感染的免疫保护持续时间。
J Travel Med. 2022 Dec 27;29(8). doi: 10.1093/jtm/taac109.
4
COVID-19 Disease Severity in Persons Infected With Omicron BA.1 and BA.2 Sublineages and Association With Vaccination Status.感染奥密克戎BA.1和BA.2亚谱系的COVID-19患者的疾病严重程度及其与疫苗接种状况的关联。
JAMA Intern Med. 2022 Oct 1;182(10):1097-1099. doi: 10.1001/jamainternmed.2022.3351.
5
Immune boosting by B.1.1.529 Omicron) depends on previous SARS-CoV-2 exposure.免疫增强作用取决于先前的 SARS-CoV-2 暴露情况。
Science. 2022 Jul 15;377(6603):eabq1841. doi: 10.1126/science.abq1841.
6
Duration of mRNA vaccine protection against SARS-CoV-2 Omicron BA.1 and BA.2 subvariants in Qatar.mRNA 疫苗预防卡塔尔奥密克戎 BA.1 和 BA.2 亚变种对 SARS-CoV-2 的保护持续时间。
Nat Commun. 2022 Jun 2;13(1):3082. doi: 10.1038/s41467-022-30895-3.
7
Assessing vaccine effectiveness against severe COVID-19 disease caused by omicron variant. Report from a meeting of the World Health Organization.评估针对奥密克戎变异株引起的严重 COVID-19 疾病的疫苗有效性。世界卫生组织会议报告。
Vaccine. 2022 Jun 9;40(26):3516-3527. doi: 10.1016/j.vaccine.2022.04.069. Epub 2022 May 2.
8
Effect of mRNA Vaccine Boosters against SARS-CoV-2 Omicron Infection in Qatar.mRNA 疫苗加强剂对卡塔尔奥密克戎感染的保护效果。
N Engl J Med. 2022 May 12;386(19):1804-1816. doi: 10.1056/NEJMoa2200797. Epub 2022 Mar 9.